Advisor Group’s Editas Medicine EDIT Stock Holding History

Advisor Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$46K	Hold	1,567	–	–	﹤0.01%	3471
2019 Q3	$36K	Sell	1,567 -179	-10%	-$4.43K	﹤0.01%	3600
2019 Q2	$43K	Buy	1,746 +150	+9%	+$3.58K	﹤0.01%	3477
2019 Q1	$39K	Sell	1,596 -21	-1%	-$475	﹤0.01%	3550
2018 Q4	$37K	Buy	1,617 +134	+9%	+$3.65K	﹤0.01%	3401
2018 Q3	$47K	Sell	1,483 -11,031	-88%	-$356K	﹤0.01%	3341
2018 Q2	$448K	Buy	12,514 +373	+3%	+$13.2K	0.01%	1391
2018 Q1	$403K	Buy	12,141 +10,280	+552%	+$366K	0.01%	1468
2017 Q4	$57K	Buy	1,861 +260	+16%	+$6.55K	﹤0.01%	2979
2017 Q3	$39K	Sell	1,601 -200	-11%	-$3.81K	﹤0.01%	3114
2017 Q2	$30K	Buy	1,801 +201	+13%	+$3.62K	﹤0.01%	3197
2017 Q1	$36K	Buy	+1,600	New	+$33.2K	﹤0.01%	2965
2016 Q4	–	Sell	-200	Closed	-$3K	–	4530
2016 Q3	$3K	Hold	200	–	–	﹤0.01%	4060
2016 Q2	$4K	Buy	+200	New	+$6.75K	﹤0.01%	3855

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Advisor Group's EDIT Position: Q4 2019 in Review

Advisor Group held its Editas Medicine (EDIT) position steady in Q4 2019 at 1,567 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

Advisor Group first reported a position in EDIT in Q2 2016 and has held it in 14 quarters since. The position peaked at $448K in Q2 2018. 229 funds tracked by Wall St. Rank hold EDIT as of Q4 2019.

Advisor Group held 1,567 shares of Editas Medicine worth $46K as of Q4 2019.
Advisor Group left its Editas Medicine share count unchanged in Q4 2019.
Editas Medicine made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3471 holding.
Advisor Group first reported a position in Editas Medicine in Q2 2016 and has held it in 14 quarters since.
Advisor Group's Editas Medicine position peaked at $448K in Q2 2018.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.